- Home
- PYPD vs EBON Comparison
PYPD vs EBON Comparison
Compare PYPD & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- EBON
- Stock Information
- Founded
- PYPD 2008
- EBON 2010
- Country
- PYPD Israel
- EBON China
- Employees
- PYPD N/A
- EBON N/A
- Industry
- PYPD Medical/Dental Instruments
- EBON Semiconductors
- Sector
- PYPD Health Care
- EBON Technology
- Exchange
- PYPD Nasdaq
- EBON Nasdaq
- Market Cap
- PYPD 25.0M
- EBON 21.2M
- IPO Year
- PYPD 2020
- EBON 2020
- Fundamental
- Price
- PYPD $2.66
- EBON $3.61
- Analyst Decision
- PYPD Strong Buy
- EBON
- Analyst Count
- PYPD 2
- EBON 0
- Target Price
- PYPD $10.50
- EBON N/A
- AVG Volume (30 Days)
- PYPD 10.9K
- EBON 7.0K
- Earning Date
- PYPD 05-07-2025
- EBON 05-02-2025
- Dividend Yield
- PYPD N/A
- EBON N/A
- EPS Growth
- PYPD N/A
- EBON N/A
- EPS
- PYPD N/A
- EBON N/A
- Revenue
- PYPD N/A
- EBON $3,591,648.00
- Revenue This Year
- PYPD N/A
- EBON N/A
- Revenue Next Year
- PYPD N/A
- EBON N/A
- P/E Ratio
- PYPD N/A
- EBON N/A
- Revenue Growth
- PYPD N/A
- EBON N/A
- 52 Week Low
- PYPD $2.30
- EBON $3.00
- 52 Week High
- PYPD $5.09
- EBON $10.94
- Technical
- Relative Strength Index (RSI)
- PYPD 52.19
- EBON 41.83
- Support Level
- PYPD $2.65
- EBON $3.25
- Resistance Level
- PYPD $2.76
- EBON $3.55
- Average True Range (ATR)
- PYPD 0.10
- EBON 0.25
- MACD
- PYPD 0.03
- EBON 0.04
- Stochastic Oscillator
- PYPD 96.98
- EBON 45.59
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.